Welcome to LookChem.com Sign In|Join Free
The company logo of Jiangsu Allyrise Pharmaceutical Co., Ltd.(expird)

Jiangsu Allyrise Pharmaceutical Co., Ltd.(expird)

Free supplier Enterprise Certification

Free
supplier
11th
years

Jiangsu Allyrise Pharmaceutical Co., Ltd.(expird)

Business Type:Trading Company

Audited Supplier

Main Products:
Year Established:
2014
Home>>Products>>2-C-Methyl-D-ribono-1,4-lactone

Product Certification&
Enterprise Certification

More Detail

Jiangsu Allyrise Pharmaceutical Co., Ltd.(expird)

Country: China (Mainland)

Business Type:Trading Company

2-C-Methyl-D-ribono-1,4-lactone

CAS NO.492-30-8

  • Min.Order: 0 Metric Ton
  • Payment Terms:
Contact Supplier

Product Details

Keywords

  • 3,4-Dihydroxy-5-(hydroxymethyl)-3-methyloxolan-2-one
  • supply 2-C-Methyl-D-ribono-1,4-lactone
  • 2-C-Methyl-D-ribono-1,4-lactone 98%

Quick Details

  • ProName: 2-C-Methyl-D-ribono-1,4-lactone
  • CasNo: 492-30-8
  • Molecular Formula: C6H10 O5
  • Appearance: white powder
  • Application: pharmaceutical intermediate
  • PackAge: bottle; drum; as per your customers' r...
  • ProductionCapacity: Metric Ton/Day
  • Purity: 98%
  • Storage: store in cool place. Keep container ti...
  • LimitNum: 0 Metric Ton

Superiority

Details

 

 

Trading information  

 

Product Name2-C-Methyl-D-ribono-1,4-lactone
CAS No.492-30-8
Molecular Formula C6H10O5
Molecular Weight162.1406
Appearancewhite powder
Purity98.0%
Package

aluminium foil bag; drum

Payment TermsL/C; D/A; D/P; T/T
Deliveryby air; by ship

 

 

 

Sample Service

 

Considering the various needs of buyers, we provide small quantity sample to customers. You are welcomed to contact us for the detailed specifications of our APIs and pharmaceutical intermediates. Customers are also expected to confirm the type of freight transport and  payment. Any more question please contact us directly.

 

 

 

 

Application of Telaprevir in the Field of Medicine

 

Telaprevir (VX-950) is a highly selective and potent inhibitor of the HCV NS3-4A serine protease. It is a member of a class of antiviral drugs known as protease inhibitors and is the first hepatitis C drug that has demonstrated activity in patients who have failed prior therapy. On April 28, 2011, the FDA Antiviral Drugs Advisory Committee voted 18-0 to recommend approval telaprevir for people with genotype 1 chronic hepatitis C and was approved in the U.S. in May, 2011.

 

 

Research and Development

 

Relying on advanced research platform and relative service of China Medicine City, Allyrise have made achievements in areas of antineoplastic, antiviral, diabetes drugs in recent years, with more than 20 kinds of APIs and advanced intermediates magnified in pilotscale experiment. The products are widely sold to famous pharmaceutical companies from around the world. To enhance our research and development level, Allyrise developed close cooperation with foreign pharmaceutical companies in customer synthesis and developing new drugs.

 

 

Technical Team

 

Jiangsu Allyrise Pharmaceutical Co., Ltd have a young and innovative technician team with average age of 29 and backgrounds of famous universerties. We have rich experience in lab research and pilot scale experiment, laying the foundation for further personnel cultivation.

 

 Allyrise lab 

 

 

Escrow Service

 

 Allyrise accept Escrow Service which is based on Lookchem as a third-party. Both buyer and seller are guranteed that their transaction is simple and secure.

 

 

Hot Product